Correlation Between Clinical and Health-related Quality-of-Life (HRQoL) Benefits in Patients With ALK plus NSCLC in ALTA-1L

被引：0
作者：
Garcia-Campelo, R. [1 ]
Lin, H. M. [2 ]
Perol, M. [3 ]
Jahanzeb, M. [4 ]
Szumski, A. [2 ]
Wu, Y. [2 ]
Geiger, A. [2 ]
Goodman, E. [2 ]
Fram, R. J. [2 ]
Popat, S. [5 ]
Camidge, D. R. [6 ]
机构：
[1] Univ Hosp A Coruna, CHUAC, La Coruna, Spain
[2] Takeda Dev Ctr Amer Inc, Lexington, MA USA
[3] Leon Berard Canc Ctr, Lyon, France
[4] Florida Canc Specialists & Res Ctr, Delray Beach, FL USA
[5] Royal Marsden Hosp, London, England
[6] Univ Colorado, Canc Ctr, Aurora, CO USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
brigatinib; quality of life; first-line therapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.10-15
引用
收藏
页码：S358 / S359
页数：2
相关论文
共 50 条
  • [1] Health-Related Quality of Life (HRQoL) Data in a Phase 3 Study of First-Line Brigatinib vs Crizotinib in NSCLC (ALTA-1L)
    Garcia Campelo, R.
    Lin, H.
    Perol, M.
    Jahanzeb, M.
    Popat, S.
    Zhu, Y.
    Zhang, P.
    Camidge, D. R.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S411 - S412
  • [2] Health-related quality of life in the randomized phase III trial of brigatinib vs crizotinib in advanced ALK inhibitor-naive ALK plus non-small cell lung cancer (ALTA-1L)
    Garcia Campelo, Maria Rosario
    Lin, Huamao M.
    Zhu, Yanyan
    Perol, Maurice
    Jahanzeb, Mohammad
    Popat, Sanjay
    Zhang, Pingkuan
    Camidge, D. Ross
    LUNG CANCER, 2021, 155 : 68 - 77
  • [3] Real-World Outcomes of 2L ALK TKIs Following 1L Brigatinib for Patients with ALK plus NSCLC from the ALTA-1L Trial
    Ahn, M. -J.
    Delmonte, A.
    Ghosh, S.
    Hochmair, M.
    Yang, T. -Y.
    Yang, J. C. -H.
    Han, J. -Y.
    Hansen, K. Holmskov
    Wu, Y.
    Wan, Y.
    Lin, H. M.
    Kretz, J.
    Hupf, B.
    Kurec, A. M.
    Churchill, E. N.
    Fram, R. J.
    Cabasag, C. J.
    Goriya, V.
    Zhao, Y.
    Gemmen, E.
    Campelo, M. R. Garcia
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S200 - S200
  • [4] Brigatinib vs Crizotinib in Patients With ALK Inhibitor-Naive Advanced ALK plus NSCLC: First Report of a Phase 3 Trial (ALTA-1L)
    Camidge, R.
    Kim, H. R.
    Ahn, M.
    Yang, J. C.
    Han, J.
    Lee, J.
    Hochmair, M.
    Li, J. Y.
    Chang, G.
    Lee, K.
    Gridelli, C.
    Delmonte, A.
    Garcia Campelo, M. R.
    Kim, D.
    Bearz, A.
    Griesinger, F.
    Morabito, A.
    Felip, E.
    Califano, R.
    Ghosh, S.
    Spira, A.
    Gettinger, S.
    Tiseo, M.
    Haney, J.
    Kerstein, D.
    Popat, S.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S184 - S185
  • [5] HEALTH-RELATED QUALITY-OF-LIFE BETWEEN NATURALISM AND HERMENEUTICS
    ROSENBERG, R
    SOCIAL SCIENCE & MEDICINE, 1995, 41 (10) : 1411 - 1415
  • [6] ASSESSING HEALTH-RELATED QUALITY-OF-LIFE IN PATIENTS WITH SCIATICA
    PATRICK, DL
    DEYO, RA
    ATLAS, SJ
    SINGER, DE
    CHAPIN, A
    KELLER, RB
    SPINE, 1995, 20 (17) : 1899 - 1908
  • [7] Determinants of subjective health-related quality of life (HRQoL) for patients with schizophrenia
    Chou, Chia-Yeh
    Ma, Mi-Chia
    Yang, Tsung-Tsair
    SCHIZOPHRENIA RESEARCH, 2014, 154 (1-3) : 83 - 88
  • [8] Correlation between clinical parameters and health-related quality of life in women with COPD
    Mangueira, Nilton Maciel
    Viega, Isabel Lucena
    Melo Maciel Mangueira, Melissa de Almeida
    Pinheiro, Alcimar Nunes
    da Silva Ramos Costa, Maria do Rosario
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2009, 35 (03) : 248 - 255
  • [9] Health-related quality of life (HRQoL) in patients with cancer and other concurrent illnesses
    Elliott, BA
    Renier, CM
    Haller, IV
    Elliott, TE
    QUALITY OF LIFE RESEARCH, 2004, 13 (02) : 457 - 462
  • [10] Health-related quality of life (HRQoL) in patients with cancer and other concurrent illnesses
    Barbara A. Elliott
    Colleen M. Renier
    Irina V. Haller
    Thomas E. Elliott
    Quality of Life Research, 2004, 13 : 457 - 462
12345